Compare ACNT & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACNT | QSI |
|---|---|---|
| Founded | 1945 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.0M | 165.3M |
| IPO Year | 1995 | N/A |
| Metric | ACNT | QSI |
|---|---|---|
| Price | $13.15 | $0.75 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 181.0K | ★ 3.1M |
| Earning Date | 05-11-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 106.72 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $618.07 |
| P/E Ratio | $147.89 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.62 | $0.73 |
| 52 Week High | $17.92 | $3.10 |
| Indicator | ACNT | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 41.46 | 35.03 |
| Support Level | $11.91 | N/A |
| Resistance Level | $16.80 | $1.11 |
| Average True Range (ATR) | 0.43 | 0.05 |
| MACD | 0.20 | -0.01 |
| Stochastic Oscillator | 80.81 | 12.01 |
Ascent Industries Co specializes in development, production, and distribution of specialty chemicals. The company produces specialty ingredients and products for the oil and gas, household, industrial and institutional, personal care, coatings, adhesive, sealants, elastomers, pulp and paper, textile, automotive, agricultural, water, treatment, and construction industries. The products of the company include: Surfactants, Defoamers, Flame Retardants, Emulsifiers, Lubricants, Plasticizers, Straight Esters and Others.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.